Global Peptide CDMO Market Growth 2023-2029

Global Peptide CDMO Market Growth 2023-2029

Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.

A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.

CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.

LPI (LP Information)' newest research report, the “Peptide CDMO Industry Forecast” looks at past sales and reviews total world Peptide CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Peptide CDMO sales for 2023 through 2029. With Peptide CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide CDMO industry.

This Insight Report provides a comprehensive analysis of the global Peptide CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peptide CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Peptide CDMO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide CDMO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide CDMO.

The global Peptide CDMO market size is projected to grow from US$ 2253.1 million in 2022 to US$ 6251.5 million in 2029; it is expected to grow at a CAGR of 6251.5 from 2023 to 2029.

Bachem is the largest player of global peptide CDMO market, holds a share over 20%, other key players include PolyPeptide, AmbioPharm, and USV Peptides, etc. In terms of type, APIs and intermediates type is the largest segment, with a share about 60%, and in terms of application, the commercial segment holds share about 80 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide CDMO market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
APIs and Intermediates
FDF

Segmentation by application
Commercial
Academic Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bachem
PolyPeptide
AmbioPharm
USV Peptides
Thermo Fisher
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CordenPharma
CPC Scientific

Key Questions Addressed in this Report

What is the 10-year outlook for the global Peptide CDMO market?

What factors are driving Peptide CDMO market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Peptide CDMO market opportunities vary by end market size?

How does Peptide CDMO break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.